Skip to content

Tag: Gatifloxacin

Explore our medication guides and pharmacology articles within this category.

Understanding Zymar: Is Zymar a fluoroquinolone and what does it treat?

3 min read
Zymar (gatifloxacin ophthalmic solution) is a fourth-generation fluoroquinolone antibiotic, indicating its classification within a family of potent antibacterial agents. This means it is specifically engineered to treat bacterial eye infections by inhibiting the growth and replication of susceptible bacteria.

What is Gatiquin P Used For? A Comprehensive Guide

3 min read
Acute endophthalmitis is a severe complication following cataract surgery, with an incidence rate of 0.04% to 0.099% in developed nations. Combination medications are often prescribed post-surgery to manage inflammation and prevent infection. This article answers, 'What is Gatiquin P used for?'

What is the use of cap GTX tablet?: Exploring the Multiple Products Bearing This Name

4 min read
Confusion often arises around the product name 'cap GTX tablet' because it is not a universally recognized brand name, and similar identifiers are used for different products. Depending on the region and manufacturer, 'GTX' could refer to an antibiotic containing Gatifloxacin or a nutritional supplement formulated for liver support and immunity. It is critical to confirm the specific medication with a healthcare professional to ensure proper and safe use.

Understanding the Pharmacological Action: What Is the Action of Gatilox Eye Drops?

3 min read
According to clinical studies, gatifloxacin—the active ingredient in Gatilox eye drops—achieved a statistically superior eradication rate for causative pathogens compared to a vehicle in patients with bacterial conjunctivitis. The core of understanding what is the action of Gatilox eye drops lies in its potent antibacterial mechanism as a fourth-generation fluoroquinolone.

What is the use of Getz Tablet? A Guide to Gatifloxacin

3 min read
While once used for a variety of systemic bacterial infections, oral tablets containing the antibiotic gatifloxacin—marketed under brand names like Getz Tablet—were withdrawn from many markets, including North America, due to serious adverse effects. The primary concern was the medication's tendency to cause abnormally high or low blood sugar levels, leading to a ban on its systemic use. Today, gatifloxacin is primarily available in ophthalmic (eye drop) form for treating bacterial eye infections, as the systemic toxicity was not observed with topical application.